Prostate Adenocarcinoma

Showing NaN - NaN of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Adenocarcinoma Trial in United States (procedure, drug, dietary supplement)

Not yet recruiting
  • Prostate Adenocarcinoma
  • Biopsy
  • +3 more
  • Los Angeles, California
  • +4 more
Sep 7, 2023

Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8, Stage IIA Prostate Cancer AJCC v8 Trial in Chicago (procedure,

Not yet recruiting
  • Prostate Adenocarcinoma
  • +3 more
  • Biopsy of Prostate
  • +6 more
  • Chicago, Illinois
    Northwestern University
May 9, 2023

Work Experience in Patients With Stage I-III Prostate Cancer

Recruiting
  • Prostate Adenocarcinoma
  • +3 more
  • Interview
  • Questionnaire Administration
  • Phoenix, Arizona
  • +324 more
Dec 21, 2022

Prostate Adenocarcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in United States

Recruiting
  • Prostate Adenocarcinoma
  • +6 more
  • Gonadotrophin Releasing Hormone
  • +2 more
  • Gilbert, Arizona
  • +86 more
Sep 27, 2022

Prostate Adenocarcinoma, Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma Trial in Canada, Switzerland, United

Active, not recruiting
  • Prostate Adenocarcinoma
  • +3 more
  • Hypofractionated radiation therapy
  • +2 more
  • Birmingham, Alabama
  • +240 more
Jun 6, 2022

Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (biological,

Completed
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Cixutumumab
  • +2 more
  • Chicago, Illinois
  • +3 more
May 21, 2019

Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (Laboratory

Completed
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Washington, District of Columbia
  • +19 more
Aug 13, 2018

Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in United States (drug, other, procedure)

Completed
  • Prostate Adenocarcinoma
  • +4 more
  • Los Angeles, California
  • +14 more
Sep 18, 2017

Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (drug, other,

Terminated
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Jacksonville, Florida
  • +13 more
Aug 21, 2017

Breast Cancer, NSCLC, Melanoma Trial in United States (131-I-TM-601 (chlorotoxin))

Completed
  • Breast Cancer
  • +7 more
  • 131-I-TM-601 (chlorotoxin)
  • Birmingham, Alabama
  • +5 more
Mar 30, 2009